HIV - Strategic Insights Report (Page 12)

Highly active antiretroviral therapy

Breakthrough in HIV/AIDS Treatment: Lenacapavir Shown to be Effective Against Multidrug-Resistant HIV-1

Researchers from Ohio State University have made a significant discovery in the field of HIV/AIDS treatment, revealing that Lenacapavir (LEN), a new, first-in-class, long-acting HIV-1 capsid-targeting inhibitor, exhibits high potency against all major HIV-1 subtypes, including variants resistant to current antiretroviral therapies. The study, published in the ACS Medicinal

HIV

Trauma Prevalence Among People with HIV Exceeds General Population by 2 Times, Study Reveals

A new study has found that trauma prevalence among people with HIV (PWH) is significantly higher than in the general population in the United States. Conducted within the Florida Cohort (2019-2022), the study aimed to describe the prevalence of 12 types of traumatic experiences over a lifetime and within the

Elderly

Childhood Sexual Abuse Linked to Late-Life Depression in Adults Living with HIV

Research conducted by investigators from the University of South Carolina has uncovered a significant association between childhood sexual abuse and late-life depression in adults living with HIV. According to the study, all forms of childhood sexual abuse were linked to depression in older adults, with the highest risk associated with

Chronic diseases

Healthcare Workers' Perception of Quality of Care for HIV and Non-Communicable Diseases in South Africa

Researchers at the University of KwaZulu-Natal have conducted a mixed-mode study to explore healthcare workers' perceptions of the quality of care rendered to patients with multiple comorbidities at an urban district hospital in KwaZulu Natal, South Africa. The study aimed to identify the challenges and facilitators of integrating care

HIV

Undiagnosed HIV among Transgender Women in the United States: A Growing Concern

Researchers from the Bloomberg School of Public Health in Baltimore, Maryland, have conducted a study to investigate the prevalence of undiagnosed HIV among transgender women in the US. The study used a hybrid cohort of 2,549 participants who underwent HIV testing and sociobehavioral assessments. The results showed that 28

Antitubercular agents

HIV/AIDS Research Highlights Challenges in Implementing Tuberculosis Preventive Therapy

Researchers at the Research Institute for Tropical Medicine published a study exploring the perceptions of healthcare workers regarding the barriers and facilitators to tuberculosis preventive therapy (TPT) implementation in the Philippines and Indonesia. The study found that despite national policies and external pressures, the implementation of TPT continues to fall

Highly active antiretroviral therapy

Tuberculosis Preventive Treatment for Pregnant People With HIV: A Modeling Analysis of Clinical Benefits and Risks

Research conducted by Massachusetts General Hospital and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network has evaluated the effectiveness of tuberculosis preventive treatment (TPT) for pregnant people with human immunodeficiency virus (HIV) in South Africa. The study used a microsimulation model to compare five TPT strategies among pregnant

HIV

New Canadian Study Reveals How HIV Hides in the Body

A groundbreaking study conducted by researchers at Western University and the University of Calgary has uncovered the secrets of how HIV conceals itself in different parts of the body, evading elimination and cure even decades after infection and treatment. The findings, published in the journal Communications Medicine, reveal that HIV

Colorado State University

Breakthrough in HIV/AIDS Research: Novel Approach Targets Drug-Resistant Strains

Researchers from Colorado State University have made a significant breakthrough in HIV/AIDS research by developing a novel approach to combat drug-resistant strains of the disease. According to a new study published in Scientific Reports, the team designed a high-throughput screening platform that targets the precursor autoprocessing of the HIV-1

HIV

Increased Risk of Schizophrenia Spectrum Disorders Among People with HIV

A recent study conducted by researchers at Copenhagen University Hospital has found a significantly higher risk of schizophrenia spectrum disorders among individuals with HIV, particularly among those who contracted HIV through injection drug use. The study, which was published in the AIDS journal, analyzed data from a nationwide, population-based, matched

HIV

New HIV Prevention Therapy Set to be Approved in England and Wales

The National Institute for Health and Care Excellence (Nice) has recommended the approval of a long-acting injection, cabotegravir (CAB-LA), for HIV prevention therapy in England and Wales. This alternative to the daily pills currently used will provide an option for HIV-negative individuals at risk of infection. The rollout is expected

End users

HIV/AIDS Study Reveals Positive Attitudes Toward Mobile Health Technology in Cameroon

Research conducted in Cameroon by the World Health Organization (WHO) has shown that 78% of respondents have a good attitude toward mobile health technology, with a mean score of 4.48 ± 0.956. The study aimed to explore the attitudes of mHealth end-users and the challenges they face in integrating

See all